Iron Financial LLC acquired a new position in shares of Chemed Co. (NYSE:CHE) in the 3rd quarter, HoldingsChannel reports. The fund acquired 1,000 shares of the company’s stock, valued at approximately $418,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CHE. Krane Funds Advisors LLC acquired a new position in shares of Chemed in the 2nd quarter valued at $26,000. Advisory Services Network LLC raised its stake in shares of Chemed by 117.9% in the 2nd quarter. Advisory Services Network LLC now owns 85 shares of the company’s stock valued at $30,000 after buying an additional 46 shares in the last quarter. Harvest Fund Management Co. Ltd raised its stake in shares of Chemed by 152.9% in the 2nd quarter. Harvest Fund Management Co. Ltd now owns 177 shares of the company’s stock valued at $64,000 after buying an additional 107 shares in the last quarter. Steward Partners Investment Advisory LLC acquired a new position in shares of Chemed in the 2nd quarter valued at $92,000. Finally, Panagora Asset Management Inc. raised its stake in shares of Chemed by 613.7% in the 2nd quarter. Panagora Asset Management Inc. now owns 364 shares of the company’s stock valued at $131,000 after buying an additional 313 shares in the last quarter. 87.56% of the stock is owned by institutional investors and hedge funds.

In other Chemed news, insider David Patrick Williams sold 17,979 shares of the firm’s stock in a transaction dated Monday, August 12th. The shares were sold at an average price of $430.80, for a total value of $7,745,353.20. Following the completion of the sale, the insider now owns 34,850 shares in the company, valued at approximately $15,013,380. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director George J. Walsh III acquired 500 shares of the stock in a transaction on Wednesday, August 7th. The stock was bought at an average price of $412.86 per share, with a total value of $206,430.00. Following the transaction, the director now directly owns 4,520 shares in the company, valued at approximately $1,866,127.20. The disclosure for this purchase can be found here. Insiders sold a total of 55,035 shares of company stock valued at $23,442,542 in the last 90 days. Corporate insiders own 3.96% of the company’s stock.

A number of equities analysts have recently issued reports on the stock. Oppenheimer increased their price objective on shares of Chemed from $400.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. Royal Bank of Canada increased their price objective on shares of Chemed to $405.00 and gave the company a “sector perform” rating in a research note on Monday, July 29th. Bank of America increased their price objective on shares of Chemed from $470.00 to $500.00 and gave the company a “buy” rating in a research note on Friday, September 6th. Finally, ValuEngine cut shares of Chemed from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company’s stock. Chemed has a consensus rating of “Hold” and an average price target of $411.25.

Shares of Chemed stock traded down $2.25 during mid-day trading on Monday, reaching $415.28. 4,833 shares of the stock were exchanged, compared to its average volume of 106,223. The company has a market cap of $6.65 billion, a price-to-earnings ratio of 34.80, a price-to-earnings-growth ratio of 2.85 and a beta of 1.11. The company has a current ratio of 0.81, a quick ratio of 0.78 and a debt-to-equity ratio of 0.25. The firm has a 50-day simple moving average of $420.99 and a 200 day simple moving average of $375.07. Chemed Co. has a fifty-two week low of $260.03 and a fifty-two week high of $441.79.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Thursday, July 25th. The company reported $3.36 earnings per share for the quarter, beating the consensus estimate of $3.09 by $0.27. The firm had revenue of $473.60 million during the quarter, compared to analysts’ expectations of $471.72 million. Chemed had a net margin of 10.94% and a return on equity of 35.63%. The company’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the company posted $2.81 EPS. On average, research analysts predict that Chemed Co. will post 13.54 EPS for the current fiscal year.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Recommended Story: What is Green Investing?

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.